Company Description
Targanta Therapeutics' mission is to build a better antibiotic. The biopharmaceutical company is developing new treatments for severe,...
Key Targanta Financials
| Company Type | Public - NASDAQ (GM): TARG Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Employees | 72 |
More Targanta Financials (7 pages)
Latest Targanta Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Targanta's competition across multiple industries
Top Targanta Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Targanta Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Mark W. Leuchtenberger | Network | E-mail |
| SVP Finance and Administration, CFO, Treasurer, and Assistant Secretary | George A. Eldridge | Network | E-mail |
| VP Marketing | Gayle C. Fischer | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Targanta News
- PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS [PCT Biblio Info] (08 Jul 2008 16:55:00 EDT)
- BioWorld Today June 26, 2008 [BioWorld Today] (26 Jun 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (25 Jun 2008 23:00:00 EDT)